Abstract
Objectives: Acetazolamide (AZD) can ameliorate transient neurologic symptoms that are seen in some patients with moyamoya disease (MD), and this may be related to its effects on cerebral blow flow (CBF). In order to further understand the mechanisms we examined the effects of AZD clinically and hemodynamically in a patient with MD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
